Research into gastrointestinal infections receives the lowest level of investment relative to the burden it poses, according to a study published in the Lancet.
The study, by Michael Head, manager of the Infectious Disease Research Network at University College London, found that over a 13-year period, gastrointestinal infection research in the UK received £254 million, or 9.7 per cent, of all funding for infectious diseases.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.